Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for cholecystitis
IRCT20210119050084N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cholecystitis comparing Atorvastatin with Placebo (2 arms). Primary endpoints: Fever, Pain and 8 more. Started Mar 2021; status: completed.
02
Drugs
atorvastatin
03
Conditions
cholecystitis
Beyond the preview
Go deeper on IRCT20210119050084N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210119050084N1.